As the year comes to an end it’s a good time to look back and evaluate the performance of various groups of funds. We’ll start with the top 10 performing funds (active and non-leveraged) of the year. As you can see from this table, 2011 belonged to the bond funds. The only equity funds on the list are pharmaceutical funds at positions 7 and 10, and one look at their 1 year charts is enough to give you a good case of heartburn. Continue reading →